Current treatment approaches and trials in central sleep apnea

Rami N. Khayat; William T. Abraham

doi:10.1016/j.ijcard.2016.02.126

Current treatment approaches and trials in central sleep apnea

Rami N. Khayat, William T. Abraham

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Central sleep apnea (CSA) is one of the most common comorbidities in patients with heart failure with reduced ejection fraction and is associated with negative consequences. Despite several recent advances, there are currently no widely accepted therapies for CSA. In this review we will discuss available therapies for CSA and review the published trials addressing treatment of CSA in HFrEF patients.

Original language	English (US)
Pages (from-to)	S22-S27
Journal	International Journal of Cardiology
Volume	206
DOIs	https://doi.org/10.1016/j.ijcard.2016.02.126
State	Published - Mar 1 2016

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2016.02.126

Cite this

@article{bd35bbde6cd749feadc9bbcb654f1895,

title = "Current treatment approaches and trials in central sleep apnea",

abstract = "Central sleep apnea (CSA) is one of the most common comorbidities in patients with heart failure with reduced ejection fraction and is associated with negative consequences. Despite several recent advances, there are currently no widely accepted therapies for CSA. In this review we will discuss available therapies for CSA and review the published trials addressing treatment of CSA in HFrEF patients.",

author = "Khayat, \{Rami N.\} and Abraham, \{William T.\}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Ireland Ltd",

year = "2016",

month = mar,

day = "1",

doi = "10.1016/j.ijcard.2016.02.126",

language = "English (US)",

volume = "206",

pages = "S22--S27",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Current treatment approaches and trials in central sleep apnea

AU - Khayat, Rami N.

AU - Abraham, William T.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Central sleep apnea (CSA) is one of the most common comorbidities in patients with heart failure with reduced ejection fraction and is associated with negative consequences. Despite several recent advances, there are currently no widely accepted therapies for CSA. In this review we will discuss available therapies for CSA and review the published trials addressing treatment of CSA in HFrEF patients.

AB - Central sleep apnea (CSA) is one of the most common comorbidities in patients with heart failure with reduced ejection fraction and is associated with negative consequences. Despite several recent advances, there are currently no widely accepted therapies for CSA. In this review we will discuss available therapies for CSA and review the published trials addressing treatment of CSA in HFrEF patients.

UR - https://www.scopus.com/pages/publications/84959528282

UR - https://www.scopus.com/inward/citedby.url?scp=84959528282&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.02.126

DO - 10.1016/j.ijcard.2016.02.126

M3 - Review article

C2 - 26961738

AN - SCOPUS:84959528282

SN - 0167-5273

VL - 206

SP - S22-S27

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Current treatment approaches and trials in central sleep apnea

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this